3 Small-Cap Stocks That Could Be Big-Time Winners
Think small. It's one of the best ideas for investors seeking to reap returns that trounce the overall market.
Three Motley Fool contributors identified small-cap stocks that they think could especially become big-time winners. Here's why they chose Bluebird Bio (NASDAQ: BLUE), Travere Therapeutics (NASDAQ: TVTX), and Viking Therapeutics (NASDAQ: VKTX).
Prosper Junior Bakiny (Bluebird Bio): Bluebird Bio is a gene-editing specialist currently sporting a market cap of $402 million, putting it squarely in small-cap territory. The biotech has encountered a series of clinical and regulatory setbacks over the past three years, leading to it losing nearly 90% of its value. Yet, there could be some hope for the company.
Source Fool.com
Viking Therapeutics Inc Aktie
48,84 €
-1,38 %
Leichtes Buy-Interesse bei Viking Therapeutics Inc, mit mehr Buy- als Sell-Einschätzungen.
Das Community-Kursziel von 110 € für Viking Therapeutics Inc zeigt eine potenzielle Verdopplung im Vergleich zum aktuellen Kurs von 48.84 €.
